HER2+ve Breast Cancer by Shaheenah Dawood
Session 3 : HER2+ve Breast Cancer
Chairpersons :
A K Malhotra, S H Advan
Speaker :
Shaheenah Dawood
Association of Polymorphisms in FCGR2A and FCGR3AWith Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer Analysis of the NSABP B31 Trial
Author: Patrick G. Gavin
Reference: JAMA Oncol. 2016 Nov 3
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HER A Trial
Author: Sherene Loi
Ref erence: JAMA Oncol. 2016 Aug 1;2(8):1040-7
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial
Author: Edith A. Perez
Reference: J Natl Cancer Inst. 2016 Oct 28;109(2)